Albiotic 330 mg/100 mg Intramammary Solution

Quốc gia: Ai-len

Ngôn ngữ: Tiếng Anh

Nguồn: HPRA (Health Products Regulatory Authority)

Thành phần hoạt chất:

Lincomycin hydrochloride; Neomycin sulfate

Sẵn có từ:

Huvepharma NV

Mã ATC:

QJ51RF03

INN (Tên quốc tế):

Lincomycin hydrochloride; Neomycin sulfate

Liều dùng:

330, 100 mg/syringe

Dạng dược phẩm:

Intramammary solution

Loại thuốc theo toa:

POM: Prescription Only Medicine as defined in relevant national legislation

Nhóm trị liệu:

Cattle

Khu trị liệu:

lincomycin, combinations with other antibacterials

Chỉ dẫn điều trị:

Antibacterial

Tình trạng ủy quyền:

Authorised

Ngày ủy quyền:

2006-03-31

Đặc tính sản phẩm

Health Products Regulatory Authority
20 May 2019
CRN008WWT
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Albiotic 330 mg/100 mg Intramammary Solution
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 10 ml syringe contains:
Active substances
Lincomycin
(as Lincomycin Hydrochloride)
330
mg
Neomycin
(as Neomycin Sulphate)
100
mg
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Intramammary solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Lactating cow.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of mastitis in lactating cattle. The product is
effective against Staphylococcus species (both penicillinase and
non-penicillinase producers) including _Staphylococcus aureus,_
Streptococcus species including _Streptococcus agalactiae, _
_Streptococcus dysgalactiae _and _Streptococcus uberis, _and coliform
bacteria including _Escherichia coli_.
4.3 CONTRAINDICATIONS
None.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Use of the product should be based on susceptibility testing of the
bacteria isolated from the animal. If this is not possible,
therapy should be based on local (regional, farm level)
epidemiological information about susceptibility of the target
bacteria.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
Avoid contact with the solution. Wash hands and any exposed skin
immediately.
Health Products Regulatory Authority
20 May 2019
CRN008WWT
Page 2 of 4
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None known.
4.7 USE DURING PREGNANCY, LACTATION OR LAY
No restrictions.
4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTIONS
This product should not be used concomitantly with macrolides e.g.
erythromycins, because lincomycin and the macrolides
antagonise each other at the site of action, the 50S ribosomal
sub-unit.
4.9 AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUT